View the PDF

Includes: Mindfulness for Managing Cancer-Related Stress, Novel alpha particle therapy holds promise in prostate and bladder cancer, HLD-0915 Earns FDA Fast Track Designation in Metastatic CRPC, The perks of combining extension and Gleason score of positive surgical margins after robot-assisted radical prostatectomy, Metastasis-Directed Tx Plus ADT Slows Progression in Oligometastatic Prostate Cancer, Irreversible Electroporation Appears Effective for Intermediate-Risk Prostate Cancer, Study offers insights into optimal patient selection for HIFU in prostate cancer, Preclinical data show promise of ATNM-400 for prostate cancer, Platinum Chemotherapy in Biomarker-Selected Metastatic Castrate Resistant Prostate Cancer, Dual-mode tracer could enable surgeons to see and ‘hear’ prostate cancer, A Novel Core Needle Biopsy Instrument Designed for Targeted Biopsy, Cancer drug eliminates aggressive cancers in Phase I trial, Positive data on BOTRESO and MCS-8 highlight dual advances in prostate health, ArteraAI Prostate for Localized Prostate Cancer Prognostication Now Approved, Diet and prostate cancer, Some low-grade prostate cancers carry higher risks than biopsy suggests, Inactivation of key pathway boosts the body’s immune response against tumors, Personalizing Treatment for Patients With Metastatic Castration-Resistant Prostate Cancer, and more.